TY  - GEN
AU  - Sotirios, Grigoriou
AU  - Martínez-Martín, Pablo
AU  - Chaudhuri, Kallol Ray
AU  - Katarina, Rukavina
AU  - Valentina, Leta
AU  - Denise, Hausbrand
AU  - Björn, Falkenburger
AU  - Per, Odin
AU  - Heinz, Reichmann
PY  - 2021
DO  - 10.1002/brb3.2336
UR  - http://hdl.handle.net/20.500.12105/14198
AB  - Background: Non-motor symptoms (NMS) are integral to Parkinson's Disease (PD) and management remains a challenge. Safinamide is a novel molecule in relation to addressing NMS due to its multifocal mechanism of action with both dopaminergic and...
LA  - eng
PB  - Wiley
KW  - MAO-B inhibitor
KW  - Parkinson's disease
KW  - Glutamate
KW  - Non-motor symptoms
KW  - Pain
KW  - Safinamide
TI  - Effects of safinamide on pain in patients with fluctuating Parkinson's disease
TY  - research article
ER  -